In April 2026, AB Science announced that it had reached a final agreement with its financial creditors. This agreement provides for a two-year deferral of the repayment of the State-Guaranteed Loans ...

J-Star Holding Co., Ltd. is a global manufacturer of carbon fiber and composite material products, with a legacy in high-performance cycling components and a growing portfolio of applications across ...

AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX ®. The U.S. therapeutic neurotoxin market exceeds $3.0 ...

Statistically significant improvement with ExoPTEN: ExoPTEN-treated eyes showed a statistically significant improvement in retinal response compared with injured eyes in the control group. This ...

J. Wood Capital Advisors acted as financial advisor to Vaxcyte in connection with the note offering.

MESQUITE, Texas, Oct. 09, 2026 (GLOBE NEWSWIRE) -- National Breathe Free is proud to welcome Metro ENT and Geetha Subramanian, MD, to its network of physician-led ear, nose and throat practices.

"The issue is not the sugar itself so much as how long it stays on the teeth," said Dr. Northcott. "Sticky candy glues itself to the enamel. A child who eats gummy candies and runs off to play is ...

RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience. NEW ORLEANS, Oct. 09, 2026 (GLOBE NEWSWIRE) -- ...

HCW11-018b is Company’s lead candidate in its second-generation T-Cell Engager Program constructed using proprietary non-FC based TRBC platform technology MIRAMAR, Fla., Oct. 09, 2026 (GLOBE NEWSWIRE) ...

Dr. Kozauer and Mr. Miller each received an option to purchase 200,000 shares of LB Pharmaceuticals’ common stock. The options carry a ten-year term and an exercise price per share equal to $37.22, ...

For more information and a complete agenda, please visit www.maximgrp.com/2026-growth-summit. About Filana Therapeutics, Inc.

Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today closed its registered direct offering of 6,000,000 units, raising gross proceeds of US$7.98 million and estimated net proceeds of ...